Navigation Links
Ingenuity Systems Announces Compliance with HIPAA
Date:2/14/2013

REDWOOD CITY, Calif., Feb. 14, 2013 /PRNewswire/ -- Ingenuity® Systems, a leading provider of biomedical information and analysis solutions, today announced that it has passed the Health Insurance Portability and Accountability Act (HIPAA) audit, confirming that Ingenuity's data center and Ingenuity Variant Analysis are in compliance with relevant Federal Regulations.

HIPAA Certification mandates strong security controls for managing patient information. By meeting the HIPAA compliance guidelines and controls, Ingenuity is able to securely serve clients such as clinical researchers, molecular pathologists and medical geneticists with strict controls on patient security, while providing intuitive web-based applications for quickly analyzing and accurately interpreting the biological meaning and clinical relevance of variant level information from NGS experiments.

"Privacy and data security is of paramount importance to patients and a requirement for us to effectively serve our customers and partners," said David Lewis , Privacy Officer of Ingenuity Systems. "Our HIPAA compliance ensures that all data stored and transferred between Ingenuity and customers is protected and that we are fully prepared to handle patient data in our analysis solutions."

"Data privacy and sharing are important areas when considering data analysis tools. We handle live-patient clinical cases which are extremely sensitive to these issues," stated Bail-Lin Wu, PhD, Genetics Diagnostic Lab Director, Boston Children's Hospital. "We are happy to see Ingenuity continuing to stay at the forefront in security and privacy best practices."

HIPAA certification marks an important milestone in the work with Ingenuity's partners, Laboratory Corporation of America® Holding (LabCorp®) and others, to bring a clinical diagnostic solution to the market for interpreting and classifying large numbers of variants identified by sequencing-based molecular diagnostic tests.

About Ingenuity® Systems
Ingenuity® Systems is a leading provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems in life science research and molecular diagnostics. Today, Ingenuity's solutions are used by tens of thousands of researchers and clinicians at hundreds of leading pharmaceutical, biotechnology, academic, diagnostic and clinical institutions worldwide.


'/>"/>
SOURCE Ingenuity Systems
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Genesis Biosystems Unveils Innovative Skin Treatment at Esthétique SPA International Trade Show
2. BioPharm Systems to Host Webinar on an Add-On Solution for Oracle Clinical
3. Syngenta Licenses Plant Sensory Systems' Technology
4. Europe Anesthesia and Respiratory Devices Market Outlook to 2018 - Respiratory Devices, Respiratory Measurement Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others
5. Immunology 2013™ Travel Grants Available from R&D Systems
6. First Warning Systems and Unicorp Biotech International Strategic Partner Letter of Intent Signed Breast Cancer Early Detection
7. BioPharm Systems to Host Webinar on Self-service Account Management for Oracle Clinical, Remote Data Capture, and Thesaurus Management System
8. Plant Sensory Systems Awarded $1.8 Million from ARPA-E to Engineer Beets for Biofuel
9. Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
10. R&D Systems Publishes 100,000 Product Detail Web Pages
11. Global Membrane Bioreactor (MBR) Systems Market Worth $2,052 Million by 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... KS. (PRWEB) , ... April 28, 2017 , ... ... contract research organization (CRO) has validated a 0.2 ng/mL lower limit (LLOQ) assay ... validated a 0.5 ng/mL LLOQ assay, the ultra-low trace nicotine assay meets additional ...
(Date:4/27/2017)... ... , ... Mitotech S.A, a Luxembourg based clinical stage biotechnology company, announced positive ... a rare devastating genetic disease that leads to a sudden and rapid loss of ... patients carrying 11778, 14484 and 3460 mutations and having experienced the onset of symptoms ...
(Date:4/27/2017)... California (PRWEB) , ... April 27, 2017 , ... ... new infographic explaining why mass flow controllers based on capillary thermal mass flow ... industrial gas mass flow control applications. Over 80% of all industrial processes—such ...
(Date:4/27/2017)... April 27, 2017  Pendant Biosciences, Inc. (formerly Nanoferix, ... modification and drug delivery technologies, today announced that it ... @ Toronto . ... Pendant Biosciences, noted, "We are excited to become part ... community, and are honored to be the first ...
Breaking Biology Technology:
(Date:3/23/2017)... -- The report "Gesture Recognition and Touchless Sensing Market by Technology ... Forecast to 2022", published by MarketsandMarkets, the market is expected to be worth ... and 2022. Continue Reading ... ... ...
(Date:3/20/2017)... 20, 2017 At this year,s CeBIT Chancellor Dr. ... manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together with the ... year,s CeBIT partner country. At the largest German biometrics company the two ... face and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , ... Well Made Simple," and 23andMe , the leading ... better food choices.  Zipongo can now provide customers with ... preferences, health goals and biometrics, but also genetic markers ... choices. Zipongo,s personalized food decision support platform ...
Breaking Biology News(10 mins):